Analysis 3.8. Comparison 3 Budesonide/formoterol (BDF) versus placebo (PLA), Outcome 8 Adverse events - ’serious events’.
Review: Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Comparison: 3 Budesonide/formoterol (BDF) versus placebo (PLA)
Outcome: 8 Adverse events - ’serious events’
![]() |